No Data
No Data
No Data
No Data
No Data
Hepion Ends Phase 2 Study for NASH Drug Due to Cash Restraints
Seeking Alpha05:10
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Shares of PriceSmart, Inc. (NASDAQ:PSMT) rose sharply in today's pre-market trading as the company posted better-than-expected earnings for its second quarter. The company reported quarterly earnings
BenzingaApr 10 20:12
Madrigal Announces US Launch of NASH/MASH Drug Rezdiffra
Seeking AlphaApr 9 22:03
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares rose sharply during today's pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of NEX
BenzingaApr 8 17:15
Galmed Pharmaceuticals Ltd. (GLMD) Surges After Hours: An Unexpected Rally
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) concluded its Friday's trading session with a modest 2.8% gain, leaving investors to be cautiously optimistic. However, the post-closing activity took an unforeseen turn, with GLMD experiencing a remarkable 15% surge in after-hours trading. During the typically quieter after-hours session, GLMD's stock surged, capturing investors' attention. Trading volume spiked to ...
Stocks TelegraphApr 8 15:35
Galmed Pharmaceuticals Granted Nasdaq Extension
TipRanksMar 20 05:28
No Data
No Data